NCT01842646
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Chronic Myelomonocytic Leukemia (CMML)
Explore clinical trials studying Chronic Myelomonocytic Leukemia (CMML). Study availability and eligibility vary by location and protocol.
17 public trials
5 recruiting studies
Chronic Myelomonocytic Leukemia (CMML) trial results
NCT01613976
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
- Novartis Investigative Site Sendai, Miyagi, Japan
Completed
Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)
NCT02546284
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Mayo Clinic Cancer Center Clinical Research Rochester, Minnesota, United States
NCT00528983
- Conditions
- Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- University of Florida Gainesville, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Central Indiana Cancer Centers Indianapolis, Indiana, United States
- Kansas University Medical Center Westwood, Kansas, United States
Active, Not Recruiting
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California, Davis - Health Systems Sacramento, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
NCT04409639
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Active, Not Recruiting
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
NCT03613532
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States